Cullinan Therapeutics, Inc. ($CGEM)
Fenton Mary Kay โ Chief Financial Officer
Shares
137,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.80
Revenue:Est: $5.56M
Transaction Details
| Insider | Fenton Mary Kay |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 18, 2026 |
| Expiration Date | Feb 18, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 18, 2026 |
| Shares Purchased | 137,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 137,500 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-059637 |
| Document | View SEC Filing |